After a three-day pitch event in September, an expert jury selected fourteen outstanding translational projects for funding by the BIH / the NeuroCure cluster of excellence. The teams at SPARK-BIH and NeuroCure welcomed the new SPARKees during an onboarding event and are excited to support the translation of their medical innovation from bench to…
Scientists from the Berlin Institute of Health at Charité (BIH), together with colleagues from Germany and the UK, have found that a commonly used liver drug also affects infection with the SARS-CoV-2 coronavirus. It causes the number of ACE-2 receptors on the cells to decrease, which makes it harder for the virus to enter the cells. The…
The €500,000 Einstein Award for Promoting Quality in Research honors researchers and institutions whose work helps to fundamentally advance the quality and robustness of research findings. The recipient of this year’s international Individual Award is Canadian physician Gordon Guyatt for the development of best practices for all areas of clinical…
The monitoring and interdisciplinary research group Gene Technology Report seeks to promote an objective discourse on genetic technologies in Germany. Renowned natural scientists, social scientists, and humanities scholars present the current state of the art in the field through periodic reports and special topic volumes, taking into account…
Der Medizinische Fakultätentag (MFT) veröffentlicht Impulspapier: Exzellente Forschung und Lehre erfordern wissenschaftliche Freiräume sowie adäquate strukturelle, finanzielle und räumliche Ressourcen, deren Bereitstellung eine zentrale Managementaufgabe der fakultären Leitungsebene ist. Institutionelle Inzentivierungs- und Belohnungssysteme…
Anomalies in the formation of blood and lymphatic vessels are, thankfully, rare. Those who do have them face a lifetime of complications that can range from the mild to the life-threatening. To date, little is known about the causes, which means the diagnostic and treatment options are very limited. René Hägerling of the BIH Center for Regenerative…
Leukemia, a blood cancer, occurs when immature immune cells stop developing but keep dividing and eventually inundate the blood. There, they encounter mature and active immune cells that either recognize and kill the cancer cells or let them escape. Dr. Simon Haas, head of a BIH junior research group within the joint focus area “Single-Cell…
Every person has an individual chemical fingerprint. The composition of small molecules in the blood, such as fats or sugars, determines how our body reacts to external influences, which diseases we are susceptible to and how severe an illness will be. In an international collaboration with partners from Cambridge (UK), scientists from the Berlin…
On July 20, 2022, the European Commission and European science and higher education associations published the final agreement for research assessment reform.
